TABLE 3.
Cell lines | Groups | Sorafenib | BMS-1166 |
---|---|---|---|
IC 50 values (mg/kg) | |||
MHCC97-H | tumor volumes | 0.52 ± 0.27 | 2.59 ± 0.50 |
tumor weights | 0.11 ± 0.05 | 0.75 ± 0.38 | |
H22 | tumor volumes | 3.84 ± 0.79 | 5.66 ± 0.67 |
tumor weights | 1.04 ± 0.61 | 0.64 ± 0.48 |
Table notes: H22 cells were still inoculated into BalB/c mice, and after MHCC97-H cells were inoculated into SCID mice, the SCID mice were infused with healthy human-derived peripheral blood lymphocytes (1 × 107 cells for each time and perfumed time times). The concentrations of sorafenib: 3, 2, 1, 0.5, 0.2, 0.1 mg/kg in SCID mice and 10, 5, 2, 1, 0.5, 0.2 mg/kg in BalB/c mice; BMS-1166: 10, 5, 2, 1, 0.5, 0.2 mg/kg in SCID mice and 20, 10, 5, 2, 1, 0.5 mg/kg in BalB/c mice.